Daxor Corporation (DXR)
NASDAQ·Healthcare·Medical - Instruments & Supplies
$11.54
+5.39%
Mkt Cap $56.94M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 2, 2026 | — | $131.85K | — | — | $1.89 | — | — | — |
| Q2 2024 Jun 29, 2024 | — | $71.76K | — | — | -$0.34 | — | — | — |
| Q2 2024 May 16, 2024 | — | $82.45K | — | — | $0.72 | — | — | — |
| Q3 2023 Aug 28, 2023 | — | $80.97K | — | — | -$0.32 | — | — | — |
| Q1 2023 Mar 1, 2023 | $40.00M | $96.40K | -99.76% | — | $0.81 | — | — | — |
| Q3 2022 Aug 25, 2022 | $7.77M | $135.24K | -98.26% | — | -$0.22 | — | — | — |
| Q2 2022 May 15, 2022 | — | $152.44K | — | — | $0.78 | — | — | — |
| Q4 2021 Nov 15, 2021 | — | $125.65K | — | — | -$0.19 | — | — | — |
| Q2 2021 May 15, 2021 | $3.60M | $145.49K | -95.96% | $0.10 | $0.23 | +128.40% | — | — |
| Q4 2020 Nov 15, 2020 | $2.96M | $118.95K | -95.98% | $0.05 | -$0.85 | -1795.08% | — | — |
| Q1 2020 Feb 28, 2020 | $1.30M | $187.22K | -85.60% | -$0.04 | -$0.22 | -456.30% | — | — |
| Q2 2019 Jun 30, 2019 | — | $192.92K | — | — | $0.10 | — | — | — |
| Q1 2019 Mar 28, 2019 | — | $200.43K | — | — | -$0.06 | — | — | — |
| Q4 2018 Nov 14, 2018 | — | $229.52K | — | — | -$0.17 | — | — | — |
| Q2 2018 May 13, 2018 | — | $275.31K | — | — | -$0.17 | — | — | — |
| Q4 2017 Nov 14, 2017 | — | $276.11K | — | — | -$0.16 | — | — | — |
| Q2 2017 May 13, 2017 | — | $260.16K | — | — | -$0.05 | — | — | — |
| Q2 2016 Jun 30, 2016 | — | $273.46K | — | — | $0.43 | — | — | — |
| Q4 2015 Dec 31, 2015 | — | $394.71K | — | — | -$1.21 | — | — | — |
| Q2 2015 Jun 30, 2015 | — | $653.27K | — | — | -$1.15 | — | — | — |